Home Blog Pharmaceutical Litigation

Pharmaceutical Litigation

Invokana & Kidney Failure

Invokana & Kidney Failure

| Pharmaceutical Litigation
Type II diabetes is a life-threatening disease, and as such, those who suffer from type II diabetes often turn to medication for help in treating the illness. One such prescription medication is Invokana (canagliflozin), which helps to lower blood sugar by forcing the kidneys to remove sugar through urination. However, in June 2016, the FDA…Read the article
What is the FDA Approval Process?

What is the FDA Approval Process?

| Pharmaceutical Litigation
Before any drug can be sold to consumers in the United States, it must first be approved by the U.S. Food and Drug Administration (FDA). Unfortunately, the approval process–while it is designed to protect consumers from dangerous drugs–is not always as thorough as it should be, and many dangerous drugs are approved by the FDA.…Read the article
Stryker Hip Implants

Stryker Hip Implants

| Pharmaceutical Litigation
The number of hip replacement surgeries that take place in the United States each year is substantial, with one article stating that over the past 10 years, the number of hip replacement surgeries has doubled. While hip replacement surgeries have the potential to provide relief from pain and immobility to many, particularly elderly adults, hip implants…Read the article
Fifth Talcum Powder Trial Ends In $110M Verdict

Fifth Talcum Powder Trial Ends In $110M Verdict

| Pharmaceutical Litigation
In four of the five trials held so far, juries have linked talcum powder to ovarian cancer. The latest verdict — $110 million from a Missouri jury — included a staggering $95 million in punitive damages. Jurors determined that Johnson & Johnson was 99 percent responsible for 62-year-old Lois Slemp’s injuries and that supplier Imerys Talc was 1…Read the article
Louisiana Taxotere MDL Moves Forward

Louisiana Taxotere MDL Moves Forward

| Pharmaceutical Litigation
As of June 2017, over 1,100 Taxotere injury cases have been consolidated for pretrial purposes in the Eastern District of Louisiana, and noted women’s health attorney Marie Napoli predicts that they will settle soon and on plaintiff-friendly terms. In less than a year, the docket has mushroomed from 33 cases to 1,116. So far, U.S. DIstrict…Read the article
Napoli Shkolnik Files Lawsuit Against Opioid Manufacturers in Ohio

Napoli Shkolnik Files Lawsuit Against Opioid Manufacturers in Ohio

| Pharmaceutical Litigation
On June 5, 2017, Napoli Shkolnik filed a lawsuit against the major manufacturers and distributors of opioid pain medications on behalf of the City of Dayton, Ohio.  Dayton has been hit as hard by the opioid and heroin epidemic as anywhere else in the nation.  Despite the valiant efforts of the City and Mayor Nan…Read the article
Legal Issues In DES Daughters Cases

Legal Issues In DES Daughters Cases

| Pharmaceutical Litigation
The story behind DES daughters, a nickname which became popular around the time that an episode of the “Lou Grant Show” highlighted the issue, goes all the way back to 1938, when scientists developed Diethylstilbestrol. Today, their offspring, and the offspring of their offspring, often suffer from serious health issues that may even be life…Read the article
Stryker Accolade Hip Defects Lead to Patient Harm

Stryker Accolade Hip Defects Lead to Patient Harm

| Pharmaceutical Litigation
Stryker is one of the largest medical device and equipment manufacturing companies in the world, and is responsible for the creation of the Stryker Accolade. The Accolade (there are a number of different Accolade models, including the Accolade TMZF Plus and Accolade II, both of which have been recalled) refers to a hip stem. A…Read the article
New Jersey Law Journal Quotes Hunter Shkolnik About Diabetes Drug Lawsuit

New Jersey Law Journal Quotes Hunter Shkolnik About Diabetes Drug Lawsuit

| Pharmaceutical Litigation
In April 2016 the U.S. Food and Drug Administration (FDA) announced the need for stronger heart problem warnings on the diabetes drug saxagliptin, sold under the names Onglyza  and Kombigleze XR. A 2015  internal study conducted by the pharmaceutical companies themselves did find an increased for hospitalization for heart failure after saxagliptin use. A previous FDA bulletin…Read the article
Taxotere: What It Is and Why Some Women Are Suing

Taxotere: What It Is and Why Some Women Are Suing

| Pharmaceutical Litigation
Brand name Taxotere (docetaxel) is a the most commonly used drug in its class to treat breast cancer. According to BreastCancer.org, the drug works by interfering with the ability of cancer cells to divide, is given intravenously, and is used to treat patients suffering from both early stage breast cancer and advanced stage breast cancer.…Read the article

Contact Us

Get a free case evaluation Attorney Referral

For all other inquiry types, please Contact Us or call (844) 230-7676

GET HELP NOW